Pharmaceuticals
Developing, manufacturing and marketing medicines.
Overview
Developing, manufacturing and marketing medicines. It sits within healthcare and carries both general healthcare obligations and its own specific rules.
Drug companies need approval before marketing, must manufacture under good manufacturing practice, monitor safety after approval and follow strict rules on promotion and interactions with healthcare professionals.
Authorities in this glossary active in it include FDA, Health Canada, EMA and MHRA. It sits within healthcare.
Check the official sources below for legal scope, applicable dates and exceptions. This entry is an explanatory reference, not legal advice.
Why it matters
Regulators increasingly look at activities and outcomes in this space, so obligations follow the business model rather than the label.
Who it affects
Organisations operating in pharmaceuticals, and the vendors who serve them.
Where it sits
Ten linked steps connect where you operate to the proof that you complied.
- 01Jurisdiction
- 02Industry
- 03Activity
- 04Authority
- 05Regulation
- 06Requirement
- 07Guidance
- 08Control
- 09Evidence
- 10Enforcement
Hierarchy
- Part of
- Healthcare
- Members & authorities
- EMAFDAHealth CanadaMHRA
Connections
The terms most closely tied to Pharmaceuticals. Select one to open it.
What to do about it
- 1List the activities you actually perform.
- 2Identify the authorities and licences those activities trigger.
- 3Scope your obligation library to the sector and its activities.
- 4Set up controls and evidence for the highest-risk obligations first.
From requirement to evidence.
Tag your organisation with this sector and Regulation Layer scopes the obligation library to it.
Request early access →